Conventional CABG Or On Pump Beating Heart: A Difference In Myocardial Injury?

Similar documents
Intraoperative application of Cytosorb in cardiac surgery

EACTS Adult Cardiac Database

Myocardial enzyme release after standard coronary artery bypass grafting

Emergency surgery in acute coronary syndrome

Navigating the Dichotomies Between Literature and Your Clinical Practice

Coronary Artery Bypass Graft: Monitoring Patients and Detecting Complications

On-Pump Beating-Heart Coronary Artery Bypass: A Propensity Matched Analysis

Declaration of conflict of interest NONE

Statistical analysis plan

Minimally Invasive Aortic Surgery With Emphasis On Technical Aspects, Extracorporeal Circulation Management And Cardioplegic Techniques

A Novel Score to Estimate the Risk of Pneumonia After Cardiac Surgery

TSDA ACGME Milestones

Randomized comparison of single versus double mammary coronary artery bypass grafting: 5 year outcomes of the Arterial Revascularization Trial

Intra-operative Echocardiography: When to Go Back on Pump

Acute heart failure: ECMO Cardiology & Vascular Medicine 2012

SUPPLEMENTAL MATERIAL

Unprotected LM intervention

CORONARY: The Coronary Artery Bypass Grafting Surgery Off or On Pump Revascularization Study. Results at 1 Year

Case scenario V AV ECMO. Dr Pranay Oza

Is bypass surgery needed for elderly patients with LMT disease? From the surgical point of view

Faculty/Presenter Disclosure

The Efficacy of Low Prime Volume Completely Closed Cardiopulmonary Bypass in Coronary Artery Revascularization

Setting The setting was a hospital. The economic study was carried out in Australia.

University of Bristol - Explore Bristol Research

Revascularization after Drug-Eluting Stent Implantation or Coronary Artery Bypass Surgery for Multivessel Coronary Disease

Paris, August 28 th Gian Paolo Ussia on behalf of the CoreValve Italian Registry Investigators

Steph ani eph ani Mi M ck i MD Cleveland Clinic

Safety of Single- Versus Multi-vessel Angioplasty for Patients with AMI and Multi-vessel CAD

Warm blood cardioplegia versus cold crystalloid cardioplegia for myocardial protection during coronary artery bypass grafting surgery

Analysis of Mortality Within the First Six Months After Coronary Reoperation

TEG-Directed Transfusion in Complex Cardiac Surgery: Impact on Blood Product Usage

Off-Pump Cardiac Surgery is not Dead

Reoperative Coronary Artery Bypass Grafting: Analysis of Early And Late Outcomes

Ischemic Heart Disease Interventional Treatment

On-Pump, Beating-Heart Coronary Artery Operations in High-Risk Patients: An Acceptable Trade-off?

Should We Give Combined Antegrade-retrograde Cardioplegia Rather than Antegrade Alone in Patients with Left Main Coronary Disease?

Daryoush Samim, Enrico Ferrari, MD, FETCS, PD&MER

Retrospective Study Of Redo Cardiac Surgery In A Single Centre. R Karthekeyan, K Selvaraju, L Ramanathan, M Rakesh, S Rao, M Vakamudi, K Balakrishnan

Should We Give Combined Antegrade-Retrograde Cardioplegia Rather Than Antegrade Alone in Patients with Left Main Coronary Disease?

OPCABG for Full Myocardial Revascularisation How we do it

Thinking outside of the box Perfusion management and myocardial protection strategy for a patient with sickle cell disease

Does socio-economic status of patients have an effect on clinical outcomes after coronary artery bypass grafting surgery

On-Pump vs. Off-Pump CABG: The Controversy Continues. Miguel Sousa Uva Immediate Past President European Association for Cardiothoracic Surgery

Emergency Intraoperative Echocardiography

ECMO vs. CPB for Intraoperative Support: How do you Choose?

Surgical AVR: Are there any contraindications? Pyowon Park Samsung Medical Center Seoul, Korea

CARDIOCHIRURGIA MINI-INVASIVA: INVASIVA: efficacia per il paziente efficienza per la sanita. Dott. Davide Ricci

Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery

Remodeling of the Remnant Aorta after Acute Type A Aortic Dissection Surgery

Adults With Diagnosed Diabetes

Ray Matthews MD Professor of Clinical Medicine Chief of Cardiology University of Southern California

Surgical Mininvasive Approach for Mitral Repair Prof. Mauro Rinaldi

CORONARY ARTERY BYPASS GRAFT (CABG) MEASURES GROUP OVERVIEW

Minimally invasive direct coronary artery bypass for left anterior descending artery revascularization analysis of 300 cases

University of Florida Department of Surgery. CardioThoracic Surgery VA Learning Objectives

High Risk PCI for Heart Failure

DECLARATION OF CONFLICT OF INTEREST

Incidence and pattern of Thrombocytopenia in cardiac surgery patients

Early and One-year Outcomes of Aortic Root Surgery in Marfan Syndrome Patients

LM stenting - Cypher

Preoperative Anemia versus Blood Transfusion: Which is the Culprit for Worse Outcomes in Cardiac Surgery?

Strategies for the High Risk Redo in CHD

CABG Surgery following STEMI

Extra Corporeal Life Support for Acute Heart failure

Alfa Ferry FRCS Cardiac Surgeon OPERATIVE MANAGEMENT IN CORONARY ARTERY DISEASE

Intraoperative Echo: When to go Back on Pump

Ischemic Heart Disease Interventional Treatment

Cardiac anaesthesia. Simon May

OPCAB IS NOT BETTER THAN CONVENTIONAL CABG

Assessing Cardiac Risk in Noncardiac Surgery. Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington

Ischemic Mitral Regurgitation

Cold crystalloid versus warm blood cardioplegia in patients undergoing aortic valve replacement

Results and Treatment Strategy for Patients Undergoing Emergent Coronary Artery Bypass Grafting

Diagnostic, Technical and Medical

Monitoring and Interventions in ICU Παρακολούθηση και παρεμβάσεις στην καρδιακή ανεπάρκεια στην μονάδα εντατικής θεραπείας

IN ELECTIVE CORONARY ARTERY BYPASS GRAFTING, PREOPERATIVE TROPONIN T LEVEL PREDICTS THE RISK OF MYOCARDIAL INFARCTION

Atrial Fibrillation Predicts Worse Long Time Prognosis after CABG A 6-Year Survival Analysis

Disclosures The PREVENT IV Trial was supported by Corgentech and Bristol-Myers Squibb

Transfusion & Mortality. Philippe Van der Linden MD, PhD

CCAS CPB Workshop Curriculum Outline Perfusion: What you might not know

Ischemic Ventricular Septal Rupture

STEMI Stents What next? Arshad Khan - HNE Clinical Research Fellow. Supervisors: Prof Boyle and Attia.

A case-control study of readmission to the intensive care unit after cardiac surgery

Images have been removed from the PowerPoint slides in this handout due to copyright restrictions.

Useful? Definition of High-risk? Pre-OP/Intra-OP/Post-OP? Complication vs Benefit? Mortality? Morbidity?

Intra-operative Effects of Cardiac Surgery Influence on Post-operative care. Richard A Perryman

Acquired Cardiovascular Disease

Ischemic Mitral Valve Disease: Repair, Replace or Ignore?

When Should We Consider TAVI. (Surgeon s Viewpoint)? Pyowon Park Samsung Medical Center Seoul, Korea

Clinical Investigation and Reports. Effectiveness of Coronary Artery Bypass Grafting With or Without Cardiopulmonary Bypass in Overweight Patients

Cardiac surgery and acute kidney injury: retrospective study

Does Coronary Artery Bypass Graft Surgery Improve Survival Among Patients With End-Stage Renal Disease?

Aortic Valve Replacement or Heart Transplantation in Patients With Aortic Stenosis and Severe Left Ventricular Dysfunction

Kinsing Ko, Thom de Kroon, Najim Kaoui, Bart van Putte, Nabil Saouti. St. Antonius Hospital, Nieuwegein, The Netherlands

THE DIASTOLIC STRESS TEST: A NEW CLINICAL TOOL? THE CONCEPT OF DIASTOLIC RESERVE

CABG in the Post-Aprotinin Era: Are We Doing Better? Ziv Beckerman, David Kadosh, Zvi Peled, Keren Bitton-Worms, Oved Cohen and Gil Bolotin

Hemodynamic improvement upon levosimendan treatment in low cardiac output patients following coronary artery bypass graft

The MAIN-COMPARE Study

Department of Hematology, Sultan Qaboos University Hospital, Muscat, Oman 2. Department of Surgery, Sultan Qaboos University Hospital, Muscat, Oman 3

ISAR-LEFT MAIN: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions

Transcription:

Conventional CABG Or On Pump Beating Heart: A Difference In Myocardial Injury? Kornelis J. Koopmans Medical Center Leeuwarden Leeuwarden, The Netherlands

I have no disclosures Disclosures

Different techniques of Extra Corporeal Circulation for CABG In our hospital: Conventional CABG > heart lung machine, full bypass, cross clamping and cardioplegic arrest (CCABG) On Pump Beating Heart > Cardiohelp, partial bypass, no cross clamp (OPBH) Cannulation in both situations: aorta/two stage venous canula

Golden standard in cardiac surgery Safe and reliable way to perform cardiac surgery Possible adverse effects: Inflammatory response activation Coagulation disorders Micro-embolisation Hemodilution Conventional CABG Cross clamping with cardiac arrest > ischemia

On Pump Beating Heart Minimized system (Cardiohelp) Use of stabilizer No cardiac arrest Luxation of the heart is not a problem > increasing the flow reduces the preload Positioning of the heart is simple, although it is not completely empty Low risk of introducing venous air by active suction Disadvantages compared to conventional CABG can be reduced by minimized system

Literature: CCABG versus OPBH OPBH: a safe and simple technique > alternative for reduced ventricular function or acute myocardial infarction Significant reduction of myocardial injury by use OPBH compared to conventional CABG Most common use: high risk patients with ejection fraction < 30% What about patients with an ejection fraction >30%? Fouda M.: Coronary artery bypass surgery with on-pump beating-heart technique.asiancardiovascthorac Ann. 2007 Oct;15(5):392-5. Perrault LP, Menasché P, Peynet J, Faris B, Bel A, de Chaumaray T, Gatecel C, Touchot B, Bloch G, Moalic JM.: On-pump, beating-heart coronary artery operations in high-risk patients: an acceptable trade-off? AnnThorac Surg. 1997 Nov;64(5):1368-73. Ferrari E, Stalder N, von Segesser LK.: On-pump beating heart coronary surgery for high risk patients requiring emergency multiple coronary artery bypass grafting. JCardiothorac Surg. 2008 Jul 2;3:38. Folliguet TA, Philippe F, Larrazet F, Dibie A, Czitrom D, Le Bret E, Bachet J, Laborde F.: Beating heart revascularization with minimal extracorporeal circulation in patients with a poor ejection fraction.heartsurg Forum. 2002;6(1):19-23. Izumi Y, Magishi K, Ishikawa N, Kimura F.: On-pump beating-heart coronary artery bypass grafting for acute myocardial infarction. AnnThorac Surg. 2006 Feb;81(2):573-6.

Primary: Is there a difference in myocardial injury in patients with EF > 30% who underwent CCABG or OPBH? Hypothesis: Expectation: less myocardial injury using OPBH Secondary: The aim Is there a difference in postoperative left ventricle function? This in relation of the use of inotropics and postoperative echo?

Method Permission local ethics committee Written informed consent 40 patients: prospective randomized trial 20 patients CCABG 20 patients OPBH Inclusion criteria Elective CABG Age:18 85 years

Exclusion criteria Combined procedures Re-do CABG EF < 30% Severe aortic calcifications Renal dysfunction Anemia: Ht < 35% Known pathology leading to clotting disorders Increased pre-op cardiac markers

Extra corporeal circulation CCABG OPBH HLM HL30 Cardiohelp HCU HCU40 HU35 Priming 1500 ml 600 ml Temperature 34.0 C (93.2 F) 37.0 C (98.6 F) Cardioplegia St. Thomas II No cardioplegia ECC-flow 2.6 l/min/m 2 1.3 2,6 l/min/m 2 Ventilation Stop during ECC Adjust, don t stop

Time table

Statistics Continuous variables Kolmogorov-Smirnov-test Mean and standard deviation: unpaired t-test Median en confidance interval: Mann-Whitney U-test Categorical variable: Chi-square test A value of p < 0.05 was considered significant

Exclusion of 4 patients Results Group OPBH OPBH CCABG CCABG Reason unexpected increased Troponin T preoperative postoperative increased cardiac markers by infarction in ungraftable area; angiogram shows good function of grafts anaphylactic shock: fluids and inotropics not enough graft material available; successful PCI Postoperative: 2 cancellations (1 OPBH and 1 CCABG) for postoperative echo

Variables CCABG (n=18) OPBH (n=18) P-value Man 15 (83.3%) 14 (77.8%) 0.674 Age (years) 61.4 ± 9.6 67.1 ± 9.1 0.077 Body surface area (m 2 ) 2.08 ± 0.15 1.94 ± 0.22 0.040 Euroscore I 2.0 ± 1.8 3.1 ± 0.22 0.083 Predicted mortality EUI 1.88 ± 0.99 2.49 ± 1.21 0.108 Predicted mortality EUII 1.63 ± 0.83 1.91 ± 0.78 0.308 Coronary sclerosis 1-vessel disease 0 (0%) 1 (5.6%) 0.310 2-vessel disease 6 (33.3%) 5 (27.8%) 0.717 3-vessel disease 12 (66.7%) 12 (66.7%) 1.000 Left main disease 2 (11.1%) 1 (5.6%) 0.546 Ejection fraction left ventricle 50% 17 (94.4%) 14 (88.9%) 0.289 30 50 % 1 (5.9%) 4 (11.1%) 0.289 Diabetes Mellitus 5 (27.8%) 4 (22.2%) 0.700 Insulin dependent DM 1 (5.6%) 1 (5.6%) 1.000

Results: peroperative Variable CCABG (n=18) OPBH (n=18) P-value CPB-time (min) 94 ± 25 85 ± 20 0.260 Cross clamp time (min) 58 ± 18 0 0.000 Total number of distal anastomoses 3.8 ± 1.2 3.0 ± 0.7 0.015

Troponin T (ng/l) After induction 10 min after protamin Arrival ICU 4 hrs after arrival ICU 10 hrs after arrival ICU CCABG 11 (4-19) 112 (95-146) 206 (167-233) 272 (249-336) 265 (235-364) OPBH 0 (4-17) 85 (83-149) 124 (120-224) 183 (164-332) 189 (171-321) P-value 0.879 0.255 0.056 0.028 0.051 CK (U/l) CCABG 75 (58-123) 238 (188-317) 310 (235-362) 368 (337-522) 393 (370-650) OPBH 57 (48-99) 108 (93-135) 155 (134-187) 155 (22-424) 379 (316-617) P-value 0.159 0.000 0.000 0.033 0.506 CK-MB (U/l) CCABG 7 (3-9) 21 (17-26) 21 (18-26) 24 (19-27) 21 (18-27) OPBH 10 (5-16) 15 (14-21) 16 (15-21) 19 (18-27) 22 (19-32) P-value 0.326 0.155 0.038 0.247 0.716

Results: myocardial injury

Results: myocardial injury

Results: myocardial injury

Results: postoperative Variable CCABG (n=18) OPBH (n=18) P-value Haemodynamics Use of inotropics (no. of patients) 1 (5.6%) 3 (16.7%) 0.289 Ventilation time Ventilation time at ICU (hours) 3.5 (2.6-5.7) 3.5 (2.9-7.3) 0.681 ICU stay ICU stay (hours) 20.1 (18.6-20.5) 20.4 (17.9-25.1) 1.000

Results: postoperative Variable CCABG (n=17) OPBH (n=17) P-value Postoperative ejection fraction LV 50 % 16 (94.1%) 16 (94.1%) 1.000 30-49 % 1 (5.9%) 1(5.9%) 1.000 Postoperative echo New wall motion abnormalities 1 (5.9%) 0 0.310 New valve abnormalities 0 0 1.000 Improved wall motion compared to pre-operative 8 (47.1%) 7 (41.2%) 0.730

Fluid balance; Blood loss; Use of blood products

Variable CCABG (n=18) OPBH (n=18) P-value Fluid balance Fluid balance pre-cpb (ml) 55 ± 267 828 ± 661 0.000 Fluid balance per-cpb (ml) 1748 ± 442 1325 ± 801 0.058 Fluid balance post-cpb (ml) -181 ± 397-500 ± 696 0.100 Total fluid balance (ml) 1622 ± 548 1652 ± 972 0.908 Blood loss Blood loss OR (ml) 960 (872-1120) 1738 (1246-2165) 0.007 Blood loss ICU (ml) 498 (437-656) 498 (443-653) 0.849 Total blood loss (ml) 1405 (1370-1715) 2210 (1742-2764) 0.009 Blood transfusion Transfusion erythrocytes cellsaver (ml) 200 (158-245) 567 (401-839) 0.000 Transfusion erythrocytes (no. of patients) 1 (5.6%) 1 (5.6%) 1.000 Transfusion platelets (no. of patients) 0 0 Transfusion FFP (no. of patients) 0 0 Transfusie Haemocomplettan / fibrinogen (no. of patients) 1 (5.6%) 3 (16.7%) 0.289

Primary: In patients with an ejection fraction > 30%: OPBH shows a trend of reduced myocardial injury OPBH presents a significantly lower CK level Secondary: No difference in the use of inotropics, ventilation time, postoperative echo and stay at the ICU. Additional: Conclusion No difference in use of blood products in relation to the fluid balance in spite of a significant difference in blood loss

Conventional CABG Or On Pump Beating Heart: A Difference In Myocardial Injury? Kornelis J. Koopmans Medical Center Leeuwarden Leeuwarden, The Netherlands kees.koopmans@znb.nl